Carcinoma in-situ of the Breast

Top Rated5(1 reviews)

Carcinoma in-situ of the Breast is a Continuing Professional Development (CPD) course designed to provide healthcare professionals with an evidence-based understanding of non-invasive breast cancer conditions, including Ductal Carcinoma in Situ (DCIS) and Lobular Carcinoma in Situ (LCIS). The course explores the pathology, diagnosis, imaging, biopsy techniques, treatment pathways, patient counselling, and evolving management approaches for carcinoma in-situ of the breast. Breast carcinoma in-situ refers to abnormal cells confined within the ducts or lobules of the breast without invasion into surrounding breast tissue. While these conditions are considered non-invasive, early recognition and appropriate management are important to reduce progression risk and improve patient outcomes.

7 Modules1 hour
$169$0
Carcinoma in-situ of the Breast

Learning Outcomes

What you'll learn

  • Understand the difference between invasive breast cancer and carcinoma in-situ.
  • Differentiate between Ductal Carcinoma in Situ (DCIS) and Lobular Carcinoma in Situ (LCIS).
  • Recognise the pathology and biological behaviour of non-invasive breast lesions.
  • Outline the imaging investigations used in the diagnosis of breast carcinoma in-situ.
  • Understand biopsy techniques and pathology assessment processes.
  • Discuss treatment options including surveillance, surgery, radiation therapy, and endocrine management.
  • Identify patients who may require specialist referral and multidisciplinary care.
  • Recognise evolving approaches aimed at reducing overtreatment in selected patients.
  • Support patients through education, communication, and shared decision-making.
  • Apply evidence-based knowledge to breast cancer screening and clinical practice.

Modules

Module 1

Understanding Breast Carcinoma in-situ

Module 2

DCIS and LCIS – Key Differences

Module 3

Imaging and Diagnostic Assessment

Module 4

Biopsy, Pathology, and Risk Assessment

Module 5

Treatment Options and Patient Management

Module 6

Avoiding Overtreatment and Future Directions

Module 7

Summary

Top reviews

FA

Faida

User fromcare-learning

5

simple but informative

Posted on 27/05/2026

You May Also Like

Learn Anytime
Anywhere

Experience the next level of learning with the Care Learning app. Available on Android and iOS.

Download on the App StoreGet it on Google Play

Come and Work
with Us!

Join us as a healthcare trainer providing practical sessions to professionals and workers.

Apply for Trainer Role

In-Person Practical
Healthcare Training

Enroll in our accredited, hands-on practical training sessions to deliver better patientcentred care.

Apply for Training

Refer &
Earn Rewards.

Invite healthcare professionals to join Care Learning and earn rewards for every successful referral.

1 / 4

Frequently Asked Questions

It is a non-invasive breast condition where abnormal cells remain confined within the ducts or lobules.

DCIS occurs in the ducts and may progress to invasive cancer, while LCIS develops in the lobules and mainly indicates increased breast cancer risk.

How is carcinoma in-situ detected? It is commonly detected through breast screening mammography and confirmed with biopsy.

Mammography, ultrasound, and breast MRI may be used depending on clinical circumstances.

Selected low-risk patients may be suitable for surveillance under specialist supervision.

Multidisciplinary teams help ensure accurate diagnosis, treatment planning, and patient-centred care.